Diabetes research is on the cusp of new advances in treatment options and in understanding the underlying causes of both type 1 and type 2 diabetes. Among those are potential treatments using stem cells to regenerate a patient’s ability to produce insulin, as well as upcoming clinical trials of a vaccine that potentially could prevent type 1 diabetes.
September 24, 2010
August 17, 2010
A joint project of UCSF and the Kenya Medical Research Institute has received $7 million—the first award of a five year grant that will total about $35 million—to expand its care and support of people affected by HIV/AIDS in Kenya.
August 11, 2010
Eighteen students recently graduated from a program designed to prepare students and practitioners for leadership careers in international health policy, health care, and health research and development.
June 18, 2010
Julene Johnson is headed for Finland and Kari Radoff is going to Nicaragua as part of the J. William Fulbright Program.
June 16, 2010
James McKerrow, leader of the Sandler Center for Drug Discovery at UCSF, was honored with the 2009 Mendel Medal for his work identifying the vulnerabilities of disease-causing parasites and for devising new strategies to fight them.
June 02, 2010
The UCSF community is invited to a symposium to address unsolved health problems, such as cancer and malaria, as a tribute to the 11-year tenure of Mike Bishop, MD, former chancellor of UCSF.
May 27, 2010
Three new UCSF studies describe the wide reach of the tobacco industry and its influence on young people, military veterans and national health care reform.
May 11, 2010
The Science Coalition (TSC), a nonprofit group of 50 U.S. research universities, released a report that highlights 100 “success stories” of companies that are the result of federal investments in basic research, including seven companies affiliated with UC research.
April 05, 2010
UCSF and SEEK Development, a global health and development consulting group based in Berlin, Germany, have launched an international partnership that aims to improve global health by helping to turn scientific evidence into policy and action. The Evidence-to-Policy Initiative, or E2Pi, officially launches this week in San Francisco and Berlin, Germany.
April 02, 2010
Seth Berkley, president and CEO of the International AIDS Vaccine Initiative and one of Time magazine’s 100 Most Influential People in the World, will talk about the global hunt for a vaccine at UCSF on April 5.